Emerging visceral mycosis;Mycoses viscérales émergentes

Revue du Praticien

Volumn 51, Issue 7, 2001, Pages 742-746

  Morin, O ^a  

^a INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; FUNGUS IDENTIFICATION; FUSARIUM; IMMUNE DEFICIENCY; MYCOSIS; SCEDOSPORIUM; SKIN INFECTION; TRICHOSPORON;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; DERMATOMYCOSES; ECOLOGY; FUSARIUM; HUMANS; ITRACONAZOLE; MADUROMYCOSIS; MYCOLOGY; MYCOSES; PSEUDALLESCHERIA; RISK FACTORS; SCEDOSPORIUM; TRICHOSPORON;

EID: 0035871253     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The new fungal opportunists are coming
2. New aspects of emerging fungal pathogens: A multifaceted challenge
3. Émergence de nouveaux champignons pathogènes en médecine
4. A new species of Scedosporium associated with osteomyelitis in humans
5. Taxonomy of the medical species of Pseudallescheria and Scedosporium
6. The isolation of Allescheria boydii schear, an etiologic agent of mycetoma from soil
7. Clinical significance of Pseudallescheria boydii: A review of 10 years' experience
8. À propos de 3 observations récentes de mycose à Pseudallescheria boydii chez le malade immunodéprimé
9. Disseminated Scedosporium prolificans (S. Inflatum) infection after single-lung transplantation
10. Mycose systémique à Pseudallescheria boydii chez une patiente greffée bipulmonaire pour une mucoviscidose
11. Scedosporium inflatum: Clinical spectrum of a newly recognized pathogen
12. Clinical features of human infection with Scedosporium inflatum
13. Fusarium a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a Cancer Center and implications for management
14. Fungal peritonitis in patients receiving peritoneal dialysis: Experience with II patients and review of the literature
15. Clinical patterns of Fusarium infections in immunocompromised patients
16. Invasive Fusarium infections: A retrospective survey of 31 cases
17. Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii
18. Antifungal activity of a new triazole, voriconazole (UK-109-496) compared with three other antifungal agents tested against clinical isolates of filamentous fungi
19. Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using broth microdilution method
20. Trichosporon on humans: A practical account
21. Isolation of Trichosporon asahii from environmental materials
22. Trichosporon infection: Clinical manifestations and treatment
23. Malassezia and Trichosporon: Two emerging pathogenic basidiomycetous yeast-like fungi
24. Azole therapy for: Clinical evaluation of eight patients, experimental therapy for murine infection and review